Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed)
Department of Health and Human Services National Institutes of Health
Type
Research/project funding
Posted on:
Date limite d´inscription:
Expired
Reference Number
RFA-AI-23-060
The purpose of this Notice of Funding Opportunity (NOFO) is to support the late-stage engineering and preclinical development of innovative biological products that safely and specifically kill HIV-infected cells. Products of interest include but are not limited to broadly neutralizing antibodies (bNAbs), their derivatives, and other soluble, antibody-like molecules.
Categories: Health.
Categories: Health.
États-Unis